Evidence map›Paper›PMID 33170557›Full record

ArticleAmerican journal of medical genetics. Part A2021

Phenotypic features in MECP2 duplication syndrome: Effects of age.

Sarika U Peters, Cary Fu, Eric D Marsh, Tim A Benke, Bernard Suter, Steve A Skinner, David N Lieberman, Shannon Standridge, Mary Jones, Arthur Beisang and 6 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Rett syndrome: The Natural History Study journey.Annals of the Child Neurology Society · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Rett and Rett-related disorders: Common mechanisms for shared symptoms?Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Medical Comorbidities inChildren (Basel, Switzerland) · 2022
    Article
  12. Epilepsy & behavior reports · 2022
    Article
  13. International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 2 countries.

Sarika U PetersDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0001-7439-5402
Cary FuDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Eric D MarshChildren's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Tim A BenkeUniversity of Colorado School of Medicine, Aurora, Colorado, USA.
Bernard SuterBaylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-0127-7322
Steve A SkinnerGreenwood Genetic Center, Greenwood, South Carolina, USA.
David N LiebermanBoston Children's Hospital, Boston, Massachusetts, USA.
Shannon StandridgeCincinatti Children's Hospital, Cincinatti, Ohio, USA.
Mary JonesOakland Children's Hospital, Oakland, California, USA.
Arthur BeisangGilette Children's Specialty Healthcare, Saint Paul, Minnesota, USA.
Timothy FeymaGilette Children's Specialty Healthcare, Saint Paul, Minnesota, USA.
Peter HeydemanRush University Medical Center, Chicago, Illinois, USA.
Robin RytherWashington University School of Medicine, St. Louis, Missouri, USA.
Daniel G GlazeBaylor College of Medicine, Houston, Texas, USA.
Alan K PercyUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
Jeffrey L NeulDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USBaylor College of Medicine · USGillette Children's Specialty Healthcare · USBoston Children's Hospital · USChildren's Health Queensland Hospital and Health Service · AUChildren's Hospital of Philadelphia · USGreenwood Genetic Center · USRush University Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Colorado Denver · USWashington University in St. Louis · US

Funding

Training and Career Development ComponentU54HD061222 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PERCY, ALAN KENNETH · 2009 to 2019
$12.4M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lea K Davis · 2020 to 2026
$10.3M
Markers of Disease Progression in MECP2 Duplication SyndromeR01HD084500 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PETERS, SARIKA U · 2016 to 2020
$1.7M
Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD084500Eunice Kennedy Shriver National Institute of Child Health and Human Development U54HD061222NICHD NIH HHS P50 HD103537NICHD NIH HHS R01 HD084500NICHD NIH HHS U54 HD061222
6 · The paper itself

Abstract

backgroundMECP2 Duplication syndrome (MDS) is a rare X-linked genomic disorder that is caused by interstitial chromosomal duplications at Xq28 encompassing the MECP2 gene. Although phenotypic features in MDS have been described, there is a limited understanding of the range of severity of these features, and how they evolve with age.

methodsThe cross-sectional results of N = 69 participants (ages 6 months-33 years) enrolled in a natural history study of MDS are presented. Clinical severity was assessed using a clinician-report measure as well as a parent-report measure. Data was also gathered related to the top 3 concerns of parents as selected from the most salient symptoms related to MDS. The Child Health Questionnaire was also utilized to obtain parental reports of each child's quality of life to establish disease burden.

resultsThe results of linear regression from the clinician-reported measure show that overall clinical severity scores, motor dysfunction, and functional skills are significantly worse with increasing age. Top concerns rated by parents included lack of effective communication, abnormal walking/balance issues, constipation, and seizures. Higher levels of clinical severity were also related to lower physical health quality of life scores as reported by parents.

conclusionsThe data suggest that increasing levels of clinical severity are noted with older age, and this is primarily attributable to motor dysfunction, and functional skills. The results provide an important foundation for creating an MDS-specific severity scale highlighting the most important domains to target for treatment trials and will help clinicians and researchers define clinically meaningful changes.

Indexed as

AdolescentAdultAge FactorsChildChild, PreschoolChromosome DuplicationCost of IllnessFemaleGenetic Diseases, X-LinkedHumansInfantMaleMethyl-CpG-Binding Protein 2PhenotypeQuality of LifeSeverity of Illness IndexMECP2 protein, humanMethyl-CpG-Binding Protein 2gene duplicationpediatricsphenotype

Identifiers

PMID33170557
PMCPMC8000774
OpenAlexW3104655037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.